BNP Paribas Financial Markets’s Mersana Therapeutics MRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$818 Sell
111
-7,947
-99% -$58.6K ﹤0.01% 4351
2025
Q1
$69.3K Sell
8,058
-6,388
-44% -$55K ﹤0.01% 3346
2024
Q4
$516K Buy
14,446
+4,958
+52% +$177K ﹤0.01% 2483
2024
Q3
$448K Sell
9,488
-3,955
-29% -$187K ﹤0.01% 2205
2024
Q2
$676K Buy
13,443
+10,214
+316% +$513K ﹤0.01% 1864
2024
Q1
$362K Buy
3,229
+1,529
+90% +$171K ﹤0.01% 2367
2023
Q4
$98.6K Sell
1,700
-3,234
-66% -$188K ﹤0.01% 2690
2023
Q3
$157K Buy
4,934
+1,974
+67% +$62.7K ﹤0.01% 2518
2023
Q2
$243K Sell
2,960
-5,908
-67% -$486K ﹤0.01% 2325
2023
Q1
$911K Buy
8,868
+3,961
+81% +$407K ﹤0.01% 1821
2022
Q4
$719K Sell
4,907
-4,600
-48% -$674K ﹤0.01% 1759
2022
Q3
$1.61M Sell
9,507
-12,081
-56% -$2.04M ﹤0.01% 1561
2022
Q2
$2.49M Sell
21,588
-4,517
-17% -$522K ﹤0.01% 1164
2022
Q1
$2.6M Buy
26,105
+1,368
+6% +$136K ﹤0.01% 1231
2021
Q4
$3.85M Buy
24,737
+21,866
+762% +$3.4M 0.01% 1089
2021
Q3
$677K Buy
2,871
+2,771
+2,771% +$653K ﹤0.01% 2059
2021
Q2
$34K Sell
100
-178
-64% -$60.4K ﹤0.01% 2799
2021
Q1
$112K Buy
278
+15
+6% +$6.06K ﹤0.01% 2747
2020
Q4
$175K Sell
263
-246
-48% -$163K ﹤0.01% 2311
2020
Q3
$237K Buy
509
+353
+226% +$164K ﹤0.01% 2084
2020
Q2
$91.3K Sell
156
-289
-65% -$169K ﹤0.01% 2186
2020
Q1
$64.8K Buy
445
+99
+29% +$14.4K ﹤0.01% 2818
2019
Q4
$49.6K Buy
346
+218
+170% +$31.2K ﹤0.01% 2994
2019
Q3
$5.07K Buy
128
+2
+2% +$79 ﹤0.01% 3627
2019
Q2
$12.7K Buy
126
+19
+18% +$1.92K ﹤0.01% 3424
2019
Q1
$14.1K Buy
107
+96
+873% +$12.6K ﹤0.01% 3384
2018
Q4
$1.16K Sell
11
-8
-42% -$840 ﹤0.01% 3224
2018
Q3
$4.73K Hold
19
﹤0.01% 3414
2018
Q2
$8.45K Sell
19
-68
-78% -$30.2K ﹤0.01% 3207
2018
Q1
$34.3K Buy
87
+44
+102% +$17.4K ﹤0.01% 3152
2017
Q4
$17.5K Buy
+43
New +$17.5K ﹤0.01% 3306